CTLA4 and cancer: In several types of cancer, the receptor CTLA-4 is expressed by activated T cells, where it binds to B7 and prevents its interaction with CD28, consequently decreasing the regulation, leading to a negative regulation of T cell proliferation and IL-2 production.